Many papers suggest that TRPM8 [14], TRPV6 [15], or TRPA1 [10] could be either markers of PDAC or specific targets for cancer therapies based on their localization in the cell membrane, making them easily druggable. The gene discussed is TRPV6; the disease is cancer.